94 research outputs found
An Accurate Determination of the Exchange Constant in Sr_2CuO_3 from Recent Theoretical Results
Data from susceptibility measurements on Sr_2CuO_3 are compared with recent
theoretical predictions for the magnetic susceptibility of the
antiferromagnetic spin-1/2 Heisenberg chain. The experimental data fully
confirms the theoretical predictions and in turn we establish that Sr_2CuO_3
behaves almost perfectly like a one-dimensional antiferromagnet with an
exchange coupling of J = 1700^{+150}_{-100}K.Comment: revised and reformatted paper with new title to appear in Phys. Rev B
(Feb.1996). 3 pages (revtex) with 3 embedded figures (macro included). A
complete postscript file is available from
http://fy.chalmers.se/~eggert/expsusc.ps or by request from
[email protected]
Susceptibility of the Spin 1/2 Heisenberg Antiferromagnetic Chain
Highly accurate results are presented for the susceptibility, of
the Heisenberg antiferromagnetic chain for all temperatures, using the
Bethe ansatz and field theory methods. After going through a rounded peak,
approaches its asympotic zero-temperature value with infinite slope.Comment: 8 pages and 3 postscript figures appended (uuencoded), Revtex, Report
#:UBCTP-94-00
Relationship of Self-Reported Asthma Severity and Urgent Health Care Utilization to Psychological Sequelae of the September 11, 2001 Terrorist Attacks on the World Trade Center Among New York City Area Residents
Objective: Posttraumatic psychological stress may be associated with increases in somatic illness, including asthma, but the impact
of the psychological sequelae of the September 11, 2001 terrorist attacks on physical illness has not been well documented. The
authors assessed the relationship between the psychological sequelae of the attacks and asthma symptom severity and the utilization
of urgent health care services for asthma since September 11. Materials and Methods: The authors performed a random digit dial
telephone survey of adults in the New York City (NYC) metropolitan area 6 to 9 months after September 11, 2001. Two thousand
seven hundred fifty-five demographically representative adults including 364 asthmatics were recruited. The authors assessed
self-reported asthma symptom severity, emergency room (ER) visits, and unscheduled physician office visits for asthma since
September 11. Results: After adjustment for asthma measures before September 11, demographics, and event exposure in
multivariate models posttraumatic stress disorder (PTSD) were a significant predictor of self-reported moderate-to-severe asthma
symptoms (OR = 3.4; CI = 1.2â9.4), seeking care for asthma at an ER since September 11 (OR = 6.6; CI = 1.6 â28.0), and
unscheduled physician visits for asthma since September 11 (OR = 3.6; CI = 1.1â11.5). The number of PTSD symptoms was also
significantly related to moderate-to-severe asthma symptoms and unscheduled physician visits since September 11. Neither a panic
attack on September 11 nor depression since September 11 was an independent predictor of asthma severity or utilization in
multivariate models after September 11. Conclusions: PTSD related to the September 11 terrorist attacks contributed to symptom
severity and the utilization of urgent health care services among asthmatics in the NYC metropolitan area.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/40381/2/Fagan_Relationship of Self-Reported Asthma Severity_2003.pd
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003
PURPOSE
PNOC003 is a multicenter precision medicine trial for children and young adults with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
PATIENTS AND METHODS
Patients (3-25 years) were enrolled on the basis of imaging consistent with DIPG. Biopsy tissue was collected for whole-exome and mRNA sequencing. After radiotherapy (RT), patients were assigned up to four FDA-approved drugs based on molecular tumor board recommendations. H3K27M-mutant circulating tumor DNA (ctDNA) was longitudinally measured. Tumor tissue and matched primary cell lines were characterized using whole-genome sequencing and DNA methylation profiling. When applicable, results were verified in an independent cohort from the Children's Brain Tumor Network (CBTN).
RESULTS
Of 38 patients enrolled, 28 patients (median 6 years, 10 females) were reviewed by the molecular tumor board. Of those, 19 followed treatment recommendations. Median overall survival (OS) was 13.1 months [95% confidence interval (CI), 11.2-18.4] with no difference between patients who followed recommendations and those who did not. H3K27M-mutant ctDNA was detected at baseline in 60% of cases tested and associated with response to RT and survival. Eleven cell lines were established, showing 100% fidelity of key somatic driver gene alterations in the primary tumor. In H3K27-altered DIPGs, TP53 mutations were associated with worse OS (TP53mut 11.1 mo; 95% CI, 8.7-14; TP53wt 13.3 mo; 95% CI, 11.8-NA; P = 3.4e-2), genome instability (P = 3.1e-3), and RT resistance (P = 6.4e-4). The CBTN cohort confirmed an association between TP53 mutation status, genome instability, and clinical outcome.
CONCLUSIONS
Upfront treatment-naĂŻve biopsy provides insight into clinically relevant molecular alterations and prognostic biomarkers for H3K27-altered DIPGs
Fully transformer-based biomarker prediction from colorectal cancer histology: a large-scale multicentric study
Background: Deep learning (DL) can extract predictive and prognostic
biomarkers from routine pathology slides in colorectal cancer. For example, a
DL test for the diagnosis of microsatellite instability (MSI) in CRC has been
approved in 2022. Current approaches rely on convolutional neural networks
(CNNs). Transformer networks are outperforming CNNs and are replacing them in
many applications, but have not been used for biomarker prediction in cancer at
a large scale. In addition, most DL approaches have been trained on small
patient cohorts, which limits their clinical utility. Methods: In this study,
we developed a new fully transformer-based pipeline for end-to-end biomarker
prediction from pathology slides. We combine a pre-trained transformer encoder
and a transformer network for patch aggregation, capable of yielding single and
multi-target prediction at patient level. We train our pipeline on over 9,000
patients from 10 colorectal cancer cohorts. Results: A fully transformer-based
approach massively improves the performance, generalizability, data efficiency,
and interpretability as compared with current state-of-the-art algorithms.
After training on a large multicenter cohort, we achieve a sensitivity of 0.97
with a negative predictive value of 0.99 for MSI prediction on surgical
resection specimens. We demonstrate for the first time that resection
specimen-only training reaches clinical-grade performance on endoscopic biopsy
tissue, solving a long-standing diagnostic problem. Interpretation: A fully
transformer-based end-to-end pipeline trained on thousands of pathology slides
yields clinical-grade performance for biomarker prediction on surgical
resections and biopsies. Our new methods are freely available under an open
source license
Determinants of GBP Recruitment to Toxoplasma gondii Vacuoles and the Parasitic Factors That Control It
IFN-Îł is a major cytokine that mediates resistance against the intracellular parasite Toxoplasma gondii. The p65 guanylate-binding proteins (GBPs) are strongly induced by IFN-Îł. We studied the behavior of murine GBP1 (mGBP1) upon infection with T. gondii in vitro and confirmed that IFN-Îł-dependent re-localization of mGBP1 to the parasitophorous vacuole (PV) correlates with the virulence type of the parasite. We identified three parasitic factors, ROP16, ROP18, and GRA15 that determine strain-specific accumulation of mGBP1 on the PV. These highly polymorphic proteins are held responsible for a large part of the strain-specific differences in virulence. Therefore, our data suggest that virulence of T. gondii in animals may rely in part on recognition by GBPs. However, phagosomes or vacuoles containing Trypanosoma cruzi did not recruit mGBP1. Co-immunoprecipitation revealed mGBP2, mGBP4, and mGBP5 as binding partners of mGBP1. Indeed, mGBP2 and mGBP5 co-localize with mGBP1 in T. gondii-infected cells. T. gondii thus elicits a cell-autonomous immune response in mice with GBPs involved. Three parasitic virulence factors and unknown IFN-Îł-dependent host factors regulate this complex process. Depending on the virulence of the strains involved, numerous GBPs are brought to the PV as part of a large, multimeric structure to combat T. gondii.National Institutes of Health (U.S.)Massachusetts Life Sciences Center (New Investigator Award)National Institute of General Medical Sciences (U.S.) (Pre-Doctoral Grant in the Biological Sciences (5-T32-GM007287-33))Studienstiftung des deutschen VolkesCancer Research Institute (New York, N.Y.)Cleo and Paul Schimmel FoundationBayer HealthcareHuman Frontier Science Program (Strasbourg, France
Genes from Chagas Susceptibility Loci That Are Differentially Expressed in T. cruzi-Resistant Mice Are Candidates Accounting for Impaired Immunity
Variation between inbred mice of susceptibility to experimental Trypanosoma cruzi infection has frequently been described, but the immunogenetic background is poorly understood. The outcross of the susceptible parental mouse strains C57BL/6 (B6) and DBA/2 (D2), B6D2F1 (F1) mice, is highly resistant to this parasite. In the present study we show by quantitative PCR that the increase of tissue parasitism during the early phase of infection is comparable up to day 11 between susceptible B6 and resistant F1 mice. A reduction of splenic parasite burdens occurs thereafter in both strains but is comparatively retarded in susceptible mice. Splenic microarchitecture is progressively disrupted with loss of follicles and B lymphocytes in B6 mice, but not in F1 mice. By genotyping of additional backcross offspring we corroborate our earlier findings that susceptibility maps to three loci on Chromosomes 5, 13 and 17. Analysis of gene expression of spleen cells from infected B6 and F1 mice with microarrays identifies about 0.3% of transcripts that are differentially expressed. Assuming that differential susceptibility is mediated by altered gene expression, we propose that the following differentially expressed transcripts from these loci are strong candidates for the observed phenotypic variation: H2-Eα, H2-D1, Ng23, Msh5 and Tubb5 from Chromosome 17; and Cxcl11, Bmp2k and Spp1 from Chromosome 5. Our results indicate that innate mechanisms are not of primary relevance to resistance of F1 mice to T. cruzi infection, and that differential susceptibility to experimental infection with this protozoan pathogen is not paralleled by extensive variation of the transcriptome
Recommended from our members
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants: An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 and June 17, 2020, 614 adult patients with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascular organ support at 121 sites in 8 countries. Of these, 403 were randomized to open-label interventions within the corticosteroid domain. The domain was halted after results from another trial were released. Follow-up ended August 12, 2020. Interventions: The corticosteroid domain randomized participants to a fixed 7-day course of intravenous hydrocortisone (50 mg or 100 mg every 6 hours) (nâ=â143), a shock-dependent course (50 mg every 6 hours when shock was clinically evident) (nâ=â152), or no hydrocortisone (nâ=â108). Main Outcomes and Measures: The primary end point was organ support-free days (days alive and free of ICU-based respiratory or cardiovascular support) within 21 days, where patients who died were assigned -1 day. The primary analysis was a bayesian cumulative logistic model that included all patients enrolled with severe COVID-19, adjusting for age, sex, site, region, time, assignment to interventions within other domains, and domain and intervention eligibility. Superiority was defined as the posterior probability of an odds ratio greater than 1 (threshold for trial conclusion of superiority >99%). Results: After excluding 19 participants who withdrew consent, there were 384 patients (mean age, 60 years; 29% female) randomized to the fixed-dose (nâ=â137), shock-dependent (nâ=â146), and no (nâ=â101) hydrocortisone groups; 379 (99%) completed the study and were included in the analysis. The mean age for the 3 groups ranged between 59.5 and 60.4 years; most patients were male (range, 70.6%-71.5%); mean body mass index ranged between 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%. For the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively, the median organ support-free days were 0 (IQR, -1 to 15), 0 (IQR, -1 to 13), and 0 (-1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ support-free days among survivors). The median adjusted odds ratio and bayesian probability of superiority were 1.43 (95% credible interval, 0.91-2.27) and 93% for fixed-dose hydrocortisone, respectively, and were 1.22 (95% credible interval, 0.76-1.94) and 80% for shock-dependent hydrocortisone compared with no hydrocortisone. Serious adverse events were reported in 4 (3%), 5 (3%), and 1 (1%) patients in the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively. Conclusions and Relevance: Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support-free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions. Trial Registration: ClinicalTrials.gov Identifier: NCT02735707
An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression
Dysregulated host responses to infection can lead to organ dysfunction and sepsis, causing millions of global deaths each year. To alleviate this burden, improved prognostication and biomarkers of response are urgently needed. We investigated the use of whole-blood transcriptomics for stratification of patients with severe infection by integrating data from 3149 samples from patients with sepsis due to community-acquired pneumonia or fecal peritonitis admitted to intensive care and healthy individuals into a gene expression reference map. We used this map to derive a quantitative sepsis response signature (SRSq) score reflective of immune dysfunction and predictive of clinical outcomes, which can be estimated using a 7- or 12-gene signature. Last, we built a machine learning framework, SepstratifieR, to deploy SRSq in adult and pediatric bacterial and viral sepsis, H1N1 influenza, and COVID-19, demonstrating clinically relevant stratification across diseases and revealing some of the physiological alterations linking immune dysregulation to mortality. Our method enables early identification of individuals with dysfunctional immune profiles, bringing us closer to precision medicine in infection.peer-reviewe
- âŠ